Search Results
Search for other papers by Louis de Mestier in
Google Scholar
PubMed
Search for other papers by Jean-Baptiste Danset in
Google Scholar
PubMed
Search for other papers by Cindy Neuzillet in
Google Scholar
PubMed
Search for other papers by Vinciane Rebours in
Google Scholar
PubMed
Search for other papers by Jérôme Cros in
Google Scholar
PubMed
Search for other papers by Nadem Soufir in
Google Scholar
PubMed
Search for other papers by Pascal Hammel in
Google Scholar
PubMed
) Consortium published guidelines on the management of patients with increased risk for familial PDAC ( Canto et al. 2013 ). The aim of screening is to detect and remove precancerous lesions such as multifocal high-grade pancreatic intraepithelial neoplasia
Search for other papers by Ulrich-Frank Pape in
Google Scholar
PubMed
Search for other papers by Uta Berndt in
Google Scholar
PubMed
Search for other papers by Jacqueline Müller-Nordhorn in
Google Scholar
PubMed
Department of Hepatology and Gastroenterology, Institute for Social Medicine, Institute for Pathology, Department of Gastroenterology, Charité, Campus Virchow Klinikum
Search for other papers by Michael Böhmig in
Google Scholar
PubMed
Search for other papers by Stephanie Roll in
Google Scholar
PubMed
Search for other papers by Martin Koch in
Google Scholar
PubMed
Search for other papers by Stefan N Willich in
Google Scholar
PubMed
Search for other papers by Bertram Wiedenmann in
Google Scholar
PubMed
48.1/51.9% 78% 63% Primary tumour characteristics Primary tumour localization is detailed in Table 1 . NET of the stomach included 20 cases of ECLomas (type-I gastric NET), 11 sporadic low-grade malignant NET (type III) and 4 high-grade malignant NET
Search for other papers by Chen-Tian Shen in
Google Scholar
PubMed
Search for other papers by Zhong-Ling Qiu in
Google Scholar
PubMed
Search for other papers by Quan-Yong Luo in
Google Scholar
PubMed
hypertension. When available, all-grade (1–4) and high-grade (3–4) events according to the Common Terminology Criteria for Adverse Events (CTCAE Version 3.0; National Cancer Institute, Bethesda, MD, USA) were included in the meta-analysis. Statistical analyses
Search for other papers by Igryl S Cordero-Hernandez in
Google Scholar
PubMed
Search for other papers by Alicia C Ross in
Google Scholar
PubMed
Search for other papers by Arvind Dasari in
Google Scholar
PubMed
Search for other papers by Daniel M Halperin in
Google Scholar
PubMed
Search for other papers by Beth Chasen in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
(mitotic rate, Ki-67 index) according to the 2022 World Health Organization (WHO) classification system ( Rindi et al. 2022 ). NEC are poorly differentiated high-grade neoplasms by definition and have a high proliferation index. While NET and NEC are
Search for other papers by G Rindi in
Google Scholar
PubMed
Search for other papers by C Klersy in
Google Scholar
PubMed
Search for other papers by F Inzani in
Google Scholar
PubMed
Search for other papers by G Fellegara in
Google Scholar
PubMed
Search for other papers by L Ampollini in
Google Scholar
PubMed
Search for other papers by A Ardizzoni in
Google Scholar
PubMed
Search for other papers by N Campanini in
Google Scholar
PubMed
Search for other papers by P Carbognani in
Google Scholar
PubMed
Search for other papers by T M De Pas in
Google Scholar
PubMed
Search for other papers by D Galetta in
Google Scholar
PubMed
Search for other papers by P L Granone in
Google Scholar
PubMed
Search for other papers by L Righi in
Google Scholar
PubMed
Search for other papers by M Rusca in
Google Scholar
PubMed
Search for other papers by L Spaggiari in
Google Scholar
PubMed
Search for other papers by M Tiseo in
Google Scholar
PubMed
Search for other papers by G Viale in
Google Scholar
PubMed
Search for other papers by M Volante in
Google Scholar
PubMed
Search for other papers by M Papotti in
Google Scholar
PubMed
Institute of Anatomic Pathology, Service of Biometry and Clinical Epidemiology, Service of Pathology, Thoracic Unit, Medical Oncology Unit, Unit of Pathological Anatomy, Medical Oncology Unit of Respiratory Tract and Sarcomas, Division of Thoracic Surgery, Department of Thoracic Surgery, Division of Pathology, Division of Thoracic Surgery, Division of Pathology and Laboratory Medicine, Department of Biomedical and Clinical Sciences ‘Luigi Sacco’, Università Cattolica del Sacro Cuore – Policlinico A. Gemelli, Rome, Italy
Search for other papers by G Pelosi in
Google Scholar
PubMed
. 1998 , Marchevsky et al . 2001 , Iyoda et al . 2007 , den Bakker et al . 2010 , Righi et al . 2010 , Ha et al . 2012 ). The clinical significance of distinguishing between high-grade LCNEC and SCLC is not clear due to the overlapping survival
Search for other papers by Diana Lim in
Google Scholar
PubMed
Cancer Genetics Service, Division of Medical Oncology, National Cancer Centre, Singapore, Singapore
Search for other papers by Joanne Ngeow in
Google Scholar
PubMed
be associated with BRCA mutations, such as basal-like or triple-negative breast cancers (TNBC) and high-grade ovarian serous carcinomas (HGOSC). Few studies have included other biomarker analyses as part of their recruitment criteria ( Table 1
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, University of Tübingen, Tübingen, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Search for other papers by Stefan Zoltán Lutz in
Google Scholar
PubMed
Search for other papers by Tilman Todenhöfer in
Google Scholar
PubMed
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, University of Tübingen, Tübingen, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Search for other papers by Robert Wagner in
Google Scholar
PubMed
Search for other papers by Jörg Hennenlotter in
Google Scholar
PubMed
Search for other papers by Jana Marlene Ferchl in
Google Scholar
PubMed
Search for other papers by Marcus Oliver Scharpf in
Google Scholar
PubMed
Search for other papers by Peter Martus in
Google Scholar
PubMed
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Institute of Pharmaceutical Sciences, Department of Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany
Search for other papers by Harald Staiger in
Google Scholar
PubMed
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, University of Tübingen, Tübingen, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Search for other papers by Andreas Fritsche in
Google Scholar
PubMed
Search for other papers by Arnulf Stenzl in
Google Scholar
PubMed
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, University of Tübingen, Tübingen, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Search for other papers by Hans-Ulrich Häring in
Google Scholar
PubMed
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich, University of Tübingen, Tübingen, Germany
German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany
Search for other papers by Martin Heni in
Google Scholar
PubMed
comparable PSA levels argue against this possibility. In conclusion, we report higher prevalence of lymph node metastasis and more high-grade tumors in men with PCa and coexistent type 2 diabetes. These findings may in part explain the worse outcome in
Search for other papers by Mei Dong in
Google Scholar
PubMed
Search for other papers by James C Yao in
Google Scholar
PubMed
higher tendency of local recurrence (3–23%) and metastasis (16–23%) and a lower 5-year survival rate of 30–95% ( Travis et al . 1998 , Kaplan et al . 2003 ), and high-grade tumors, more properly classified as small cell or large cell neuroendocrine
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Urology, Keio University School of Medicine, Tokyo, Japan
Search for other papers by Hiroki Ide in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Taichi Mizushima in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Guiyang Jiang in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Takuro Goto in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Yujiro Nagata in
Google Scholar
PubMed
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Yuki Teramoto in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Satoshi Inoue in
Google Scholar
PubMed
Search for other papers by Yi Li in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Eiji Kashiwagi in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Search for other papers by Alexander S Baras in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, USA
Search for other papers by George J Netto in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Takashi Kawahara in
Google Scholar
PubMed
James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
Department of Pathology & Laboratory Medicine, University of Rochester Medical Center, Rochester, New York, USA
James P. Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, New York, USA
Department of Urology, University of Rochester Medical Center, Rochester, New York, USA
Search for other papers by Hiroshi Miyamoto in
Google Scholar
PubMed
corresponding benign-appearing urothelial tissues. All 51 patients with high-grade muscle-invasive tumor ultimately underwent radical cystectomy. Tumor progression was evaluated separately in 78 cases with non-muscle-invasive tumor (i.e. development of high-grade
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Adam W Nelson in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Wayne D Tilley in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by David E Neal in
Google Scholar
PubMed
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge CB2 0RE, UK
Department of Urology Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge CB2 0QQ, UK
Dame Roma Mitchell Cancer Research Laboratories Faculty of Health Sciences, School of Medicine, The University of Adelaide, Level 4, Hanson Institute Building, DX Number 650 801, Adelaide, South Australia 5000, Australia
Department of Oncology University of Cambridge, Cambridge CB2 2QQ, UK
Search for other papers by Jason S Carroll in
Google Scholar
PubMed
intraepithelial neoplasia (PIN – a premalignant histological phenotype which, especially when high grade or multifocal, is a recognised risk factor for the development of invasive prostate cancer ( Nelson et al . 2003 , Merrimen et al . 2009 )), whereas ArKO